Dopamine ☺️ Flashcards
Describe how dopamine is synthesised
-name a clinically useful drug
RATE LIMITING
Tyrosine from diet =(tyrosine hydroxylase)=> DOPA
DOPA =(DOPA decarboxylase)=> dopamine
-levodopa (crosses BBB, converted to D)
Describe how dopamine is stored
-name a clinically useful drug and its use
VMAT1, 2 (D 2H exchanger) => vesicle
-reserpine (blocks VMAT storage, D broken down by MAO)
Describe how dopamine is released
-name a clinically useful drug and its use
Ca dependent vesicle release at end terminals and en passant varicosities
-amantadine (D agonist, nicotinic antagonist for Parkinsonism)
Describe what 3 receptor types respond to dopamine
-name some clincally useful drugs and its uses
All GPCRs
- D1 like receptor (excitatory neurotransmission) => D1, 5 are coupled to Gs
- D2 like receptor (inhibitory neurotransmission) => D2, 3, 4 are coupled to Gi
Full agonist - apomorphine (non selective morphine agonist in advanced PD) bromocriptine (D2 agonist in PD, hyperprolactinemia, acromegaly, pituitary tumours)
Antagonists - haloperidol, chlopromazine (antipsychotic, N+V)
Describe the reuptake of dopamine
-name some clinically useful drugs and their uses
D diffuses to DAT (symport with D, Cl, 2Na)
-gradient driven by NaKATPase
Bupropion (NRT)
Methylpenidate/ritalin (ADHD)
Describe the degradation of dopamine
-name some clinically useful drugs and their uses
Majority of D =(MAO, aldehyde dehydrogenase)=> dihydroxyphenylacetic acid =(COMT)=> homovanillic acid
Some D =(COMT)=> 3-methoxydopamine =(MAO, aldehyde dehydrogenase)=> homovanillic acid
MAOi - phenelzine (depression), selegiline(PD)
COMT - entacapone, tolcapone (PD)
Describe the 2 recreational drugs that affect the dopamine pathway
Cocaine, amphetamine => highly addictive due to activation of dopamine pathway
How are these diseases implicated in dopamine signalling
- Parkinsons
- Schizophrenia
- N+V
- Hormonal disturbances
Parkinsons => loss of D secreting neurones leading to motor symptoms
Schizophrenia => psychosis caused by too much dopamine
N+V => D2 activation may cause nausea
Hormonal disturbances => dopamine agonists inhibit PRL, GH secretions
Describe the location of release
What structures are innervated
Substancia nigra and ventral tegmental area => prefrontal cortex, midbrain
Which areas of the brain are affected in PD
Dopaminergic pathway in substancia nigra, basal ganglia, caudate, putamen